Abbott India Ltd

BSE :500488 NSE :ABBOTINDIA Sector : Pharmac..
29,108.05
Change: -290.90(-0.99%)
Buy Sell SIP
52 week Low
25,200.00
52 week High
31,898.95
Day low
28,975.55
Day high
29,600.05
Prev Close
29,398.95
Open
29,009.60
6M return
1.95%
1Y return
10.26%
MCap(Rs. in Cr.)
61,854.61
Total Volume
5,194
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
46.40
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
627.98
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
17.57
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
28.17%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
1.41

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
29669.17
Resistance 2
29939.38
Support 1
29014.42
Support 2
28629.88

Moving Average

20 Days
30049.56
50 Days
29235.16
100 Days
28849.78
200 Days
28659.37
Growth in 3 years

Sales
19.11%

Sales Industry Avg
10.24%

PAT
50.40%

PAT Industry Avg
-20.95%

Dec 2024
( in Cr.)		Sep 2024
( in Cr.)		Jun 2024
( in Cr.)		Mar 2024
( in Cr.)		FY 2024
( in Cr.)
Sales1,614.281,632.671,557.611,438.635,875.26
Gross Profit505.58496.94455.59407.871,688.92
Operating Profit00000
Profit Before Tax483.58479.64439.38382.891,617.75
Tax122.80121.03111.3795.83416.53
Profit After Tax360.78358.61328.01287.061,201.22
No data available
Nov 2002
( in Cr.) 		Nov 2001
( in Cr.)
Share Capital16.2016.20
Reserves And Surplus156.39116.41
Investments146.9696.78
Total Debt2.352.66
Total Liabilities174.94135.27
Total Assets174.94135.27
1450%
2023
4100%
2024 2025
2026


Relative to Sensex rtn in 3 year
154.80%

Relative to Nifty rtn in 3 year
137.86%



1 Year (%)2 Year (%)3 Year (%)
Abbott India102762
Bse Sensex-12324
Nifty 50-12726
Nifty 500-23833

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Abbott India
29,108.05
Change: -290.90 (-0.99%)
1 Year return
10.26%
Risk (Std Dev)
0.07%
PE Ratio
46.40
MCap( in Cr.)
61,854.61
BUY SELL
Sun Pharma.Inds.
1,652.20
Change: -36.15 (-2.14%)
1 Year return
3.28%
Risk (Std Dev)
0.07%
PE Ratio
33.60659
MCap( in Cr.)
3,96,418.12
BUY SELL
Divi`s Lab.
5,386.15
Change: -1.15 (-0.02%)
1 Year return
41.89%
Risk (Std Dev)
0.06%
PE Ratio
69.14590
MCap( in Cr.)
1,42,985.36
BUY SELL
Cipla
1,415.60
Change: -16.95 (-1.18%)
1 Year return
-3.20%
Risk (Std Dev)
0.04%
PE Ratio
22.92489
MCap( in Cr.)
1,14,326.28
BUY SELL
Torrent Pharma.
3,126.80
Change: -119.80 (-3.69%)
1 Year return
20.39%
Risk (Std Dev)
0.07%
PE Ratio
56.82570
MCap( in Cr.)
1,05,820.37
BUY SELL
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 1,10,256.10 with a Gain of 10.26%

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

Results Update 15 Aug 2020 7:44 PM
Abbott India Ltd Q1FY21 Results Comment
As compared to the previous quarter, Revenue in Q1FY21 has witnessed a growth of 10.73% and amounts to Rs.1064.3 Cr. The Revenue also gone up by 6.55% over Q1FY20.
Results Update 17 Jun 2020 3:51 PM
Abbott India Ltd Q4FY20 Results Comment
In comparison with the previous quarter, Revenue in Q4FY20 has gone up by 10.85% and amounts to Rs. 961.2 Cr.
Institutional Reports 22 Sep 2019 10:18 PM
Tax axe: Surprise gift for corporates!
Finance Minister Nirmala Sitharaman's surprise announcement of a corporate tax cut (to 22%) has fired the animal instincts of Indian stock markets. New companies in the manufacturing sector will be t..
View More

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

D D
2023
D
2024
2025

News

Stay tuned to the latest developments and happenings in the company.

Abbott India announces change in senior management

Abbott India announced that Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her resignation from e....

20 Feb 2025 09:28

Abbott India standalone net profit rises 16.01% in the December 2024 quarter

Net profit of Abbott India rose 16.01% to Rs 360.78 crore in the quarter ended December 2024 as against Rs 310.98 crore during the previous quarter en....

05 Feb 2025 15:13

Abbott India appoints Commercial Director - GI Business

The Board of Abbott India at its meeting held on 05 February 2025 has appointed Harshraj Madan as Commercial Director - GI Business effective 17 Febru....

05 Feb 2025 14:17

Abbott India to hold board meeting

Abbott India will hold a meeting of the Board of Directors of the Company on 5 February 2025.Powered by Capital Market - Live News</p....

28 Jan 2025 15:04

Abbott India standalone net profit rises 14.59% in the September 2024 quarter

Net profit of Abbott India rose 14.59% to Rs 358.61 crore in the quarter ended September 2024 as against Rs 312.94 crore during the previous quarter e....

07 Nov 2024 14:16

Abbott India standalone net profit rises 13.01% in the June 2024 quarter

Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 as against Rs 290.24 crore during the previous quarter ended ....

08 Aug 2024 07:29

View More
Subscribe for our
newsletter
Open Account Now